VETRANO, ERICA
 Distribuzione geografica
Continente #
EU - Europa 2.576
AS - Asia 1.226
NA - Nord America 949
SA - Sud America 159
AF - Africa 17
Totale 4.927
Nazione #
RU - Federazione Russa 2.075
US - Stati Uniti d'America 926
SG - Singapore 371
CN - Cina 254
VN - Vietnam 225
HK - Hong Kong 182
IT - Italia 179
IE - Irlanda 132
BR - Brasile 126
KR - Corea 70
IN - India 52
DE - Germania 50
GB - Regno Unito 35
FR - Francia 24
JP - Giappone 17
MX - Messico 14
PL - Polonia 10
NL - Olanda 9
AR - Argentina 8
AT - Austria 8
FI - Finlandia 8
SE - Svezia 7
TR - Turchia 7
BD - Bangladesh 6
CO - Colombia 6
EG - Egitto 6
ID - Indonesia 6
PK - Pakistan 6
CA - Canada 5
LT - Lituania 5
PE - Perù 5
UA - Ucraina 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
PT - Portogallo 4
ZA - Sudafrica 4
BO - Bolivia 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
SA - Arabia Saudita 3
BE - Belgio 2
CZ - Repubblica Ceca 2
ES - Italia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
PY - Paraguay 2
RS - Serbia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.927
Città #
Moscow 747
Singapore 195
San Jose 184
Hong Kong 175
Dublin 126
Santa Clara 103
Chandler 81
Ho Chi Minh City 75
Ashburn 70
Hefei 70
Seoul 70
The Dalles 62
Hanoi 50
New York 41
Naples 39
Bengaluru 30
Beijing 26
Dallas 25
Los Angeles 25
Da Nang 17
Munich 17
São Paulo 13
Orem 12
Cambridge 11
Princeton 11
Roxbury 11
Caserta 10
Falkenstein 10
Atlanta 8
Haiphong 8
Salerno 8
Chennai 7
Hải Dương 7
Liveri 7
Bremen 6
Hillsboro 6
Milan 6
Stockholm 6
Tokyo 6
Warsaw 6
Amsterdam 5
Can Tho 5
Chicago 5
Florence 5
Frankfurt am Main 5
Lahore 5
Mexico City 5
Vienna 5
Baku 4
Belo Horizonte 4
Biên Hòa 4
Brasília 4
Brooklyn 4
Damietta 4
Denver 4
Des Moines 4
Helsinki 4
Houston 4
Istanbul 4
Lisbon 4
Manchester 4
Paris 4
Seattle 4
Yên Bái 4
Zurich 4
Andover 3
Bexley 3
Boydton 3
Chengdu 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Ha Long 3
Johannesburg 3
La Paz 3
Lappeenranta 3
Lima 3
Manaus 3
Mumbai 3
Nha Trang 3
Norwalk 3
Nuremberg 3
Phoenix 3
Rio de Janeiro 3
Rome 3
Shenzhen 3
Terzigno 3
Toronto 3
Addis Ababa 2
An Giang Province 2
Andria 2
Asunción 2
Athens 2
Avellino 2
Banda Aceh 2
Bari 2
Belgrade 2
Bishkek 2
Boardman 2
Bogotá 2
Totale 2.588
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 181
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 179
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 155
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 155
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 150
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 149
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 149
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 147
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 143
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 138
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
HCC and molecular targeting therapies: Back to the future 133
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 127
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 125
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 123
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 122
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 122
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 122
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 122
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 120
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 120
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 115
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 115
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 115
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 113
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 113
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 110
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 110
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 107
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 100
null 93
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 90
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 87
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 87
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 86
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 86
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 81
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 79
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 76
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 67
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 66
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 51
Totale 4.994
Categoria #
all - tutte 15.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 2 10
2021/202294 1 0 0 17 20 6 4 2 3 2 11 28
2022/2023292 17 15 8 17 35 16 4 22 133 8 5 12
2023/2024234 31 11 6 18 47 36 4 9 5 15 22 30
2024/2025712 6 13 3 11 103 76 102 68 133 65 59 73
2025/20263.648 193 234 199 118 324 1.909 295 190 125 61 0 0
Totale 4.994